Drug Trial Radar · NCT07165028
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Last checked: Nov 19, 2026Latest source record: Oct 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
4,500
Planned (sponsor's estimate)
Start
Oct 15, 2025
Primary completion
Aug 2030
Study completion Aug 2032
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Sep 10, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of the SYNERGY-OUTCOMES study is to find out whether retatrutide and tirzepatide can prevent major adverse liver outcomes (MALO) in people with high-risk metabolic dysfunction-associated steatotic liver disease (MASLD). The study will enroll adults who have MASLD based on non-invasive tests (NITs), which indicate they are more likely to develop MALO. Participants will be randomly assigned within a Master Protocol to receive either retatrutide (N1T-MC-RT01), tirzepatide (N1T-MC-TZ01) or placebo. The trial plans to enroll about 4,500 adults and will run for approximately 224 weeks. Participants may have up to approximately 25 to 30 clinic visits throughout the study to monitor their health, complete study procedures, and assess liver function and disease progression. Once the study is complete, eligible participants may participate in an optional 2-year extension study, in which all participants will receive either retatrutide or tirzepatide, even if they received placebo in the main study.
Conditions
- Metabolic Dysfunction-Associated Steatotic Liver Disease
Interventions
TirzepatideDrug
Administered SC
RetatrutideDrug
Administered SC
PlaceboDrug
Administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to First Occurrence of Any Component of the Composite Endpoint for Major Adverse Liver Outcomes (MALO)Time frame: Baseline up to Study Completion (about 224 weeks)
Locations
563 sites in 34 countries. Site status is shown where the registry gives one.
MFA Clinical Research
Tuscaloosa, Alabama · Recruiting
The Institute for Liver Health II dba Arizona Clinical Trials - Chandler
Chandler, Arizona · Recruiting
Spectrum Research Institute
Gilbert, Arizona · Recruiting
The Institute for Liver Health II dba Arizona Liver Health - Peoria
Peoria, Arizona · Recruiting
Epic Medical Research-Sun City
Sun City, Arizona · Recruiting
The Institute for Liver Health II dba Arizona Clinical Trials - Tucson
Tucson, Arizona · Recruiting
Del Sol Research Management, LLC
Tucson, Arizona · Recruiting
Arkansas Gastroenterology - North Little Rock
North Little Rock, Arkansas · Recruiting
San Fernando Valley Health Institute
Canoga Park, California · Recruiting
Ark Clinical Research - Fountain Valley
Fountain Valley, California · Recruiting
Fresno Clinical Research Center
Fresno, California · Recruiting
UCSD - Altman Clinical and Translational Research Institute (ACTRI)
La Jolla, California · Recruiting
Orange County Research Center
Lake Forest, California · Recruiting
Om Research LLC
Lancaster, California · Recruiting
Ark Clinical Research
Long Beach, California · Recruiting
Los Angeles Institute for Metabolic Research
Los Angeles, California · Recruiting
United Medical Doctors - Murrieta
Murrieta, California · Recruiting
Knowledge Research Center
Orange, California · Recruiting
California Liver Research Center
Pasadena, California · Recruiting
Artemis Institute for Clinical Research
Riverside, California · Recruiting
Medical Associates Research Group
San Diego, California · Recruiting
Quest Clinical Research
San Francisco, California · Recruiting
University of Colorado Anschutz Medical Campus
Aurora, Colorado · Recruiting
South Denver Gastroenterology
Englewood, Colorado · Recruiting
Medical Research Center of Connecticut
Hamden, Connecticut · Recruiting
K2 Medical Research WINTER GARDEN
Clermont, Florida · Recruiting
K2 Medical Research - Daytona Beach
Daytona Beach, Florida · Recruiting
Care Access - Delray Beach
Delray Beach, Florida · Recruiting
AMR Clinical
Doral, Florida · Recruiting
Southwest General Healthcare Center
Fort Myers, Florida · Recruiting
University of Florida College of Medicine
Gainesville, Florida · Recruiting
Encore Medical Research
Hollywood, Florida · Recruiting
Nature Coast Clinical Research - Inverness
Inverness, Florida · Recruiting
Encore Borland-Groover Clinical Research
Jacksonville, Florida · Recruiting
Health Awareness
Jupiter, Florida · Recruiting
K2 MEDICAL Research THE VILLAGES
Lady Lake, Florida · Recruiting
Florida Research Institute
Lakewood Rch, Florida · Recruiting
Tampa Bay Medical Research - Largo
Largo, Florida · Recruiting
Evolution Clinical Trials
Miami, Florida · Recruiting
Floridian Clinical Research, LLC
Miami Lakes, Florida · Recruiting
Showing 40 of 563 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.